DOI: 10.1055/s-00000142

Frauenheilkunde up2date

References

Colombo N, Gadducci A, Sehouli J. et al.
LBA30 INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs. carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6–12 months after last platinum line.

Ann Oncol 2020;
31: S1161

Download Bibliographical Data

Access: